These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2834967)

  • 21. Contribution of vascular and tubular effects of arginine-vasopressin to the development of deoxycorticosterone acetate (DOCA)-salt hypertension in rats.
    Hofbauer KG; Mah SC; Wood JM; Baum HP; Hänni H; Opperman JR; Kraetz J
    J Hypertens Suppl; 1984 Dec; 2(3):S333-5. PubMed ID: 6599676
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vasopressin and water distribution in rats with DOCA-salt hypertension.
    Kunes J; Nedvídek J; Zicha J
    J Hypertens Suppl; 1989 Dec; 7(6):S204-5. PubMed ID: 2632718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Augmentation by chlorpropamide of 1-deamino-8-D-arginine vasopressin-induced antidiuresis and stimulation of renal medullary adenylate cyclase and accumulation of adenosine 3',5'-monophosphate.
    Moses AM; Coulson R
    Endocrinology; 1980 Mar; 106(3):967-72. PubMed ID: 6243558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 1-desamino-8-D-arginine vasopressin (DDAVP) as an agonist on V1b vasopressin receptor.
    Saito M; Tahara A; Sugimoto T
    Biochem Pharmacol; 1997 Jun; 53(11):1711-7. PubMed ID: 9264324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of aquaporin-2 gene expression in hyponatremic rats with chronic vasopressin-induced antidiuresis.
    Saito T; Higashiyama M; Nagasaka S; Sasaki S; Saito T; Ishikawa SE
    Kidney Int; 2001 Oct; 60(4):1266-76. PubMed ID: 11576341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AVP-induced increase in AQP2 and p-AQP2 is blunted in heart failure during cardiac remodeling and is associated with decreased AT1R abundance in rat kidney.
    Lütken SC; Frøkiær J; Nielsen S
    PLoS One; 2015; 10(2):e0116501. PubMed ID: 25658446
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vasopressin-stimulated CFTR Cl- currents are increased in the renal collecting duct cells of a mouse model of Liddle's syndrome.
    Chang CT; Bens M; Hummler E; Boulkroun S; Schild L; Teulon J; Rossier BC; Vandewalle A
    J Physiol; 2005 Jan; 562(Pt 1):271-84. PubMed ID: 15513933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. V2-like vasopressin receptor mobilizes intracellular Ca2+ in rat medullary collecting tubules.
    Champigneulle A; Siga E; Vassent G; Imbert-Teboul M
    Am J Physiol; 1993 Jul; 265(1 Pt 2):F35-45. PubMed ID: 8342613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vasopressin regulation of inner medullary collecting ducts and compensatory changes in mice lacking adenosine A1 receptors.
    Rieg T; Pothula K; Schroth J; Satriano J; Osswald H; Schnermann J; Insel PA; Bundey RA; Vallon V
    Am J Physiol Renal Physiol; 2008 Mar; 294(3):F638-44. PubMed ID: 18199602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal function contributes to antihypertensive effect of vasopressin in DOCA-salt but not spontaneous hypertension.
    Wang H; McNeill JR
    Am J Physiol; 1994 Nov; 267(5 Pt 2):H1842-50. PubMed ID: 7977814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Internal sodium balance in DOCA-salt rats: a body composition study.
    Titze J; Bauer K; Schafflhuber M; Dietsch P; Lang R; Schwind KH; Luft FC; Eckardt KU; Hilgers KF
    Am J Physiol Renal Physiol; 2005 Oct; 289(4):F793-802. PubMed ID: 15914779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of diazoxide on serum and tissue electrolyte levels in rats with deoxycorticosterone acetate-induced hypertension.
    Nakai T
    J Pharm Sci; 1994 May; 83(5):704-7. PubMed ID: 8071825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vasopressin induces vascular superoxide via endothelin-1 in mineralocorticoid hypertension.
    Li L; Galligan JJ; Fink GD; Chen AF
    Hypertension; 2003 Mar; 41(3 Pt 2):663-8. PubMed ID: 12623976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A comparative study of C19 steroid-induced hypertension and deoxycorticosterone acetate (DOCA)-salt hypertension].
    Minato M; Honda M; Hatano M
    Nihon Naibunpi Gakkai Zasshi; 1990 Jan; 66(1):29-41. PubMed ID: 2307256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vasopressin-V2 receptor stimulation reduces sodium excretion in healthy humans.
    Bankir L; Fernandes S; Bardoux P; Bouby N; Bichet DG
    J Am Soc Nephrol; 2005 Jul; 16(7):1920-8. PubMed ID: 15888562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sodium excretion during elevation of renal venous pressure: modulation by dDAVP.
    Firth JD; Raine AE; Ledingham JG
    Am J Physiol; 1989 May; 256(5 Pt 2):F776-9. PubMed ID: 2719115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interactions between ADH and prostaglandins in isolated erythrocyte-perfused rat kidney.
    Lieberthal W; Vasilevsky ML; Valeri CR; Levinsky NG
    Am J Physiol; 1987 Feb; 252(2 Pt 2):F331-7. PubMed ID: 3812744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antinatriuretic effect of vasopressin in humans is amiloride sensitive, thus ENaC dependent.
    Blanchard A; Frank M; Wuerzner G; Peyrard S; Bankir L; Jeunemaitre X; Azizi M
    Clin J Am Soc Nephrol; 2011 Apr; 6(4):753-9. PubMed ID: 21233458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sodium transport by rat cortical collecting tubule. Effects of vasopressin and desoxycorticosterone.
    Reif MC; Troutman SL; Schafer JA
    J Clin Invest; 1986 Apr; 77(4):1291-8. PubMed ID: 2420830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alterations of renal V1 and V2 receptors in spontaneously hypertensive rats and DOCA-salt hypertensive rats using computerized quantification for macro-autoradiogram.
    Mimura Y; Ogura T; Kataoka H; Oishi T; Asano N; Kishida M; Yamauchi T; Ogawa N; Makino H
    Res Commun Mol Pathol Pharmacol; 1997 Jan; 95(1):43-56. PubMed ID: 9055348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.